Published Year: 2020
Global Liquid Biopsy Market: Focus on Market Segmentation by Product Type, by Indication Type, by Te
The global liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Product Definition
1.2 Scope of the Study
1.3 Key Questions Answered in the Report
2.1 Data Sources
2.1.1 Primary Data Sources
2.1.2 Secondary Data Sources
2.2 Market Estimation Model
2.2.1 Factors Considered for Data Prediction and Modeling
2.2.2 Assumptions and Limitations
3.1 Business Drivers
3.1.1 Need for Non-Invasive Diagnosis
3.1.2 Advancements in Single Cell Sequencing Techniques
3.1.3 Increase in Adoption of Personalized Medicine
3.2 Business Challenges
3.2.1 Lack of Tools for Computational Analysis
3.2.2 High Capital Requirement
3.2.3 Lack of Infrastructure and Expertise
3.3 Legal Requirements and Regulations
3.3.1 Legal Requirements and Framework in the U.S.
3.3.2 Legal Requirements and Regulations in Europe
3.3.3 Legal Requirements and Framework in Asia-Pacific
3.3.3.1 China
3.3.3.2 Japan
3.4 Opportunity MAP (Markets – Applications – Products)
3.4.1 Expansion into Emerging Markets
3.4.2 Expansion into New Research Application
3.4.3 Expansion of the Product Portfolio
4.1 Single Cell Isolation
4.1.1 Fluorescence-Activated Cell Sorting (FACS)
4.1.2 Laser Capture Microdissection (LCM)
4.1.3 Microfluidics
4.1.4 Digital Dielectrophoretic Sorting (DEPArray)
4.1.5 Other Technologies
4.2 Single Cell Amplification
4.2.1 Multiple Displacement Amplification (MDA)
4.2.1.1 Micro-Capillary Array Emulsion Multiple Displacement Amplification (MiCA-eMDA)
4.2.1.2 Single Droplet Multiple Displacement Amplification (sd-MDA)
4.2.1.3 Compartmented Droplet Multiple Displacement Amplification (Cd-MDA)
4.2.2 Multiple Annealing and Looping-Bases Amplification (MALBAC)
4.2.3 Polymerase Chain Reaction (ddPCR and DOP-PCR)
4.2.4 Linear Amplification via Transposon Insertion (LIANTI)
4.2.5 Other Technologies
4.3 Single Cell Sequencing
4.3.1 Single Cell Transcriptome Sequencing (Sc-RNA Sequencing)
4.3.2 Single Cell Whole Genome Sequencing (WGS)
4.3.3 Single Cell Genome and Transcriptome Parallel Sequencing
4.3.4 Single Cell Hi-C Sequencing
4.3.5 Single Cell Reduced Representation Bisulfite Sequencing (scRRBS)
4.3.6 Single Cell Whole-Genome Bisulfite Sequencing (WGBS)
4.4 Affiliated Technological Advancements
4.4.1 Advancements in Imaging Techniques for Single Cell Sequencing
4.4.2 Advancements in Single Cell Collection and Analysis System
5.1 Instruments
5.1.1 Next-Generation Sequencing Systems
5.1.2 Polymerase Chain Reaction
5.1.3 Microarray Systems
5.1.4 Flow Cytometer
5.1.5 Others
5.2 Consumables
5.2.1 Assay Kits
5.2.2 Beads
5.2.3 Microplates
5.2.4 Other Consumables
6.1 Oncology
6.2 Immunology
6.3 Neurology
6.4 Microbiology
6.5 Pre-Natal Diagnosis (NIPT)
6.6 Others
7.1 Single Cell Sequencing End User Types
7.1.1 Research and Academic Laboratories
7.1.2 Biopharmaceutical and Biotech Companies
7.1.3 Others (Hospitals, Clinics, and Diagnostic Labs)
7.2 Single Cell Sequencing End User Preferences
7.2.1 End User Preference and Satisfaction Level of Different Instruments (by Brand)
7.2.2 End User Preference for Cell Types Used in Single Cell Sequencing
7.2.3 End User Preferred Technology for Single Cell Isolation
7.2.4 End User Perception for Challenges in Single Cell Sequencing
8.1 Growth Rates and Market Shares of Key Players
8.2 Business Strategies
8.2.1 Product Launches
8.2.2 Expanding Presence through Partnerships, Joint Ventures, and Collaborations
8.3 Corporate Developments
8.3.1 Mergers and Acquisitions
8.3.2 Funding
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 Australia
9.4.4 India
9.4.5 South Korea
9.4.6 Singapore
9.4.7 Rest-of-APAC
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World
10.1 10x Genomics Inc.
10.1.1 Company Overview
10.1.2 Role of 10x Genomics Inc. in the Global Single Cell Sequencing Market
10.1.3 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Role of Becton, Dickinson and Company in the Global Single Cell Sequencing Market
10.2.3 Key Insights About Financial Health of the Company
10.2.4 SWOT Analysis
10.3 Bio-Rad Laboratories, Inc.
10.3.1 Company Overview
10.3.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Sequencing Market
10.3.3 Key Insights About Financial Health of the Company
10.3.4 SWOT Analysis
10.4 BGI Genomics Co. Ltd.
10.4.1 Company Overview
10.4.2 Role of BGI in the Single-Cell Sequencing Market
10.4.3 SWOT Analysis
10.5 Celsee Inc.
10.5.1 Company Overview
10.5.2 Role of Celsee Inc. in the Global Single Cell Sequencing Market
10.5.3 SWOT Analysis
10.6 Fluidigm Corporation
10.6.1 Company Overview
10.6.2 Role of Fluidigm Corporation in the Global Single Cell Sequencing Market
10.6.3 Key Insights About Financial Health of the Company
10.6.4 SWOT ANALYSIS
10.7 Fluxion Biosciences
10.7.1 Company Overview
10.7.2 Role of Fluxion Biosciences in the Global Single Cell Sequencing Market
10.7.3 SWOT Analysis
10.8 Illumina, Inc.
10.8.1 Company Overview
10.8.2 Role Illumina, Inc. in the Global Single Cell Sequencing Market
10.8.3 Key Insights About Financial Health of the Company
10.8.4 SWOT Analysis
10.9 Mission Bio
10.9.1 Company Overview
10.9.2 Role of Mission Bio in the Single Cell Sequencing Market
10.9.3 SWOT Analysis
10.10 NanoString Technologies, Inc.
10.10.1 Company Overview
10.10.2 Role of NanoString Technologies, Inc. in the Global Single Cell Sequencing Market
10.10.3 Key Insights About Financial Health of the Company
10.10.4 SWOT Analysis
10.11 PerkinElmer, Inc.
10.11.1 Company Overview
10.11.2 Role of PerkinElmer, Inc. in the Global Single Cell Sequencing Market
10.11.3 Key Insights About Financial Health of the Company
10.11.4 SWOT Analysis
10.12 QIAGEN N.V.
10.12.1 Company Overview
10.12.2 Role of QIAGEN N.V. in the Global Single Cell Sequencing Market
10.12.3 Key Insights About Financial Health of the Company
10.12.4 SWOT Analysis
10.13 Takara Bio, Inc.
10.13.1 Company Overview
10.13.2 Role of Takara Bio, Inc. in the Global Single Cell Sequencing Market
10.13.3 Key Insights About Financial Health of the Company
10.13.4 SWOT Analysis
10.14 Thermo Fisher Scientific Inc.
10.14.1 Company Overview
10.14.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell Sequencing Market
10.14.3 Financials
10.14.4 Key Insights About Financial Health of the Company
10.14.5 SWOT Analysis
Table 1: Impact Analysis
Table 2: Impact Analysis: Market Restraints
Table 3.1: Regulatory Bodies and Consortiums of Single Cell Sequencing Market
Table 3.2: Classification of Directive Groups IVDs
Table 4.1: Products for Fluorescence-Activated Cell Sorting
Table 4.2: Multiple Annealing and Looping-Based Amplification-Based Products for Single Cell Analysis
Table 4.3: PCR-Based Products for Single Cell Isolation
Table 4.4: Products Offered for Single Cell Transcriptome Sequencing
Table 4.5: Products Offered for Single Cell Whole Genome Sequencing
Table 8.1: Single Cell Sequencing Research Funding
Figure 1: Market Dynamics of Global Single Cell Sequencing Market
Figure 2: Drivers of Next-Generation Sequencing Market
Figure 3: Restraints of Next-Generation Sequencing Market
Figure 4: Global Single Cell Sequencing Market Snapshot
Figure 5: Dominating Segments of the Global Single Cell Sequencing, 2018 and 2029
Figure 6: Global Single Cell Sequencing Market Share (by Product), 2018-2029
Figure 7: Global Single Cell Sequencing Market Share (by Workflow), 2018-2029
Figure 8: Global Single Cell Sequencing Market Share (by End User), 2018-2029
Figure 9: Global Single Cell Sequencing Market Share (by Application), 2018-2029
Figure 1.1: Global Single Cell Sequencing Market Segmentation
Figure 2.1: Global Single Cell Sequencing Market Research Methodology
Figure 2.2: Bottom-Up Approach (Segment-Wise Analysis)
Figure 2.3: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Single Cell Isolation Methods
Figure 4.2: Global Single Cell Isolation Market, 2018-2029
Figure 4.3: Global Single Cell Fluorescence-Activated Cell Sorting Market, 2018-2029
Figure 4.4: Global Single Cell Laser Capture Microdissection Market, 2018-2029
Figure 4.5: Global Single Cell Microfluidics Market, 2018-2029
Figure 4.6: Global Single Cell DEPArray Market, 2018-2029
Figure 4.7: Global Single Cell Other Single Cell Isolation Technologies Market, 2018-2029
Figure 4.8: Global Single Cell Sequencing Amplification Market, 2018-2029
Figure 4.9: Global Single Cell Sequencing Multiple Displacement Amplification Market, 2018-2029
Figure 4.10: Global Single Cell Micro-Capillary Array Emulsion Multiple Displacement Amplification Market, 2018-2029
Figure 4.11: Global Single Droplet Multiple Displacement Amplification Market, 2018-2029
Figure 4.12: Global Compartmented Droplet Multiple Displacement Amplification Market, 2018-2029
Figure 4.13: Global Single Cell MALBAC Market, 2018-2029
Figure 4.14: Global Single Cell Polymerase Chain Reaction (ddPCR and DOP-PCR) Market, 2018-2029
Figure 4.15: Global Single LIANTI Market, 2018-2029
Figure 4.16: Global Single Cell Other Amplification Technologies Market, 2018-2029
Figure 4.17: Global Single Cell Sequencing Market, 2018-2029
Figure 4.18: Global Single Cell Transcriptome Sequencing Market, 2018-2029
Figure 4.19: Global Single Cell Whole Genome Sequencing (WGS) Market, 2018-2029
Figure 4.20: Global Single Cell Genome and Transcriptome Parallel Sequencing Market, 2018-2029
Figure 4.21: Global Single Cell Hi-C Sequencing Market, 2018-2029
Figure 4.22: Global Single Cell Reduced Representation Bisulfide Sequencing Market, 2018-2029
Figure 4.23: Global Single Cell Whole Genome Bisulfite Sequencing Market, 2018-2029
Figure 4.24: Three Major Technological Developments in Single Cell Sequencing
Figure 4.25: Traditional and Modern Approaches for Single Cell Isolation
Figure 5.1: Global Single Cell Sequencing (by Product Type), 2018 and 2029
Figure 5.2: Global Single Cell Sequencing Instruments Market, 2018-2029
Figure 5.3: Global Single Cell Sequencing NGS System Market, 2018-2029
Figure 5.4: Global Single Cell Sequencing PCR Market, 2018-2029
Figure 5.5: Global Single Cell Sequencing Microarray Systems Market, 2018-2029
Figure 5.6: Global Single Cell Sequencing Flow Cytometer Market, 2018-2029
Figure 5.7: Global Single Cell Sequencing Other Instruments Market, 2018-2029
Figure 5.8: Global Single Cell Sequencing Consumables Market, 2018-2029
Figure 5.9: Global Single Cell Sequencing Assay Kits Market, 2018-2029
Figure 5.10: Global Single Cell Sequencing Beads Market, 2018-2029
Figure 5.11: Global Single Cell Sequencing Microplates Market, 2018-2029
Figure 5.12: Global Single Cell Sequencing Other Consumables Market, 2018-2029
Figure 6.1: Global Single Cell Sequencing Market for Oncology (2018-2029)
Figure 6.2: Global Single Cell Sequencing Market for Immunology (2018-2029)
Figure 6.3: Global Single Cell Sequencing Market for Neurology (2018-2029)
Figure 6.4: Global Single Cell Sequencing Market for Microbiology (2018-2029)
Figure 6.5: Global Single Cell Sequencing Pre-Natal Market (2018-2029)
Figure 6.6: Global Single Cell Sequencing Other Application Market (2018-2029)
Figure 7.1: Global Single Cell Sequencing Market (Research and Academia), 2018-2029
Figure 7.2: Global Single Cell Sequencing Market, (Biopharmaceutical and Biotech Companies), 2018-2029
Figure 7.3: Global Single Cell Sequencing Market (Others), 2018-2029
Figure 7.4: End User Preference of Instruments (by Major Brand) (N=35)
Figure 7.5: End User Satisfaction Level of Instruments (by Brand) (N=35) (1 being lowest and 5 being the highest)
Figure 7.6: Customer Preference for Cell Types Used in Single Cell Sequencing (N=35)
Figure 7.7: End User Preferred Technology for Single Cell Isolation (N=35)
Figure 7.8: End User Perception on Challenges in Single Cell Sequencing (N=35) (where 1= not limiting and 5= extremely limiting)
Figure 8.1: Growth Rate and Market Share Matrix for Global SCS Market, 2018
Figure 8.2: Market Shares of Key Players in Global Single Cell Sequencing Market, 2018
Figure 8.3: Product Launches Share (by Companies), January 2016–April 2019
Figure 8.4: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 8.5: Number of Acquisitions (by Company), January 2016–April 2019
Figure 9.1: Global Single Cell Sequencing Market (by Region), 2018 and 2029
Figure 9.2: Global Single Cell Sequencing Market (by Region), 2018-2029
Figure 9.3: Global Single Cell Sequencing Market Share (by Region), 2018
Figure 9.4: Global Single cell Sequencing Market Share (by Region), 2029
Figure 9.5: North America Global Single Cell Sequencing Market, 2018-2029
Figure 9.6: North America: Market Dynamics
Figure 9.7: North America Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.8: U.S. Single Cell Sequencing Market, 2018-2029
Figure 9.9: Canada Single Cell Sequencing Market, 2018-2029
Figure 9.10: Europe Single Cell Sequencing Market, 2018-2029
Figure 9.11: Europe: Market Dynamics
Figure 9.12: Europe Global Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.13: Germany Single Cell Sequencing Market, 2018-2029
Figure 9.14: France Single Cell Sequencing Market, 2018-2029
Figure 9.15: U.K. Single Cell Sequencing Market, 2018-2029
Figure 9.16: Italy Single Cell Sequencing Market, 2018-2029
Figure 9 17: Spain Single Cell Sequencing Market, 2018-2029
Figure 9.18: Rest-of-Europe Single Cell Sequencing Market, 2018-2029
Figure 9.19: Asia-Pacific Single Cell Sequencing Market, 2018-2029
Figure 9.20: APAC: Market Dynamics
Figure 9.21: APAC Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.22: China Single Cell Sequencing Market, 2018-2029
Figure 9.23: Japan Single Cell Sequencing Market, 2018-2029
Figure 9.24: Australia Single Cell Sequencing Market, 2018-2029
Figure 9.25: India Single Cell Sequencing Market, 2018-2029
Figure 9.26: South Korea Single Cell Sequencing Market, 2018-2029
Figure 9.27: Singapore Single Cell Sequencing Market, 2018-2029
Figure 9.28: RoAPAC Single Cell Sequencing Market, 2018-2029
Figure 9.29: Latin America Single Cell Sequencing Market, 2018-2029
Figure 9.30: Latin America: Market Dynamics
Figure 9.31: Latin America Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.32: Brazil Single Cell Sequencing Market, 2018-2029
Figure 9.33: Mexico Single Cell Sequencing Market, 2018-2029
Figure 9.34: Rest-of-Latin America Single Cell Sequencing Market, 2018-2029
Figure 9.35: RoW Single Cell Sequencing Market, 2018-2029
Figure 10.1: 10x Genomics Inc.: SWOT Analysis
Figure 10.2: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 10.3: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
Figure 10.4: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
Figure 10.5: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 10.6: Becton, Dickinson and Company: SWOT Analysis
Figure 10.7: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
Figure 10.8: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.9: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 10.10: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
Figure 10.11: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.12: BGI: SWOT Analysis
Figure 10.13: Celsee Inc.: SWOT Analysis
Figure 10.14: Fluidigm Corporation: Overall Financials, 2016-2018
Figure 10.15: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
Figure 10.16: Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 10.17: Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 10.18: Fluidigm Corporation: SWOT Analysis
Figure 10.19: Fluxion Biosciences: SWOT Analysis
Figure 10.20: Illumina Inc.: Overall Financials, (2016-2018)
Figure 10.21: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.22: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 10.23: Illumina, Inc., R&D Expenditure, 2016-2018
Figure 10.24: Illumina, Inc. SWOT Analysis
Figure 10.25: Mission Bio: SWOT Analysis
Figure 10.26: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
Figure 10.27: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.28: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 10.29: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 10.30: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), 2016-2018
Figure 10.31: NanoString Technologies: SWOT Analysis
Figure 10.32: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 10.33: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.34: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 10.35: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
Figure 10.36: PerkinElmer, Inc.: SWOT Analysis
Figure 10.37: QIAGEN N.V..: Overall Financials, (2015-2017)
Figure 10.38: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
Figure 10.39: QIAGEN N.V.: Revenue (by Region), 2015-2017
Figure 10.40: QIAGEN N.V.: R&D Expenditure, 2015-2017
Figure 10.41: QIAGEN N.V.: SWOT Analysis
Figure 10.42: Takara Bio Inc.: Overall Financials, (2016-2018)
Figure 10.43: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.44: Takara Bio, Inc.: Revenue (by Region), 2017
Figure 10.45: Takara Bio, Inc., R&D Expenditure, 2015-2017
Figure 10.46: Takara Bio Inc.: SWOT Analysis
Figure 10.47: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.48: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.49: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 10.50: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 10.51: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 10.52: Thermo Fisher Scientific Inc.: SWOT Analysis
Report Description
Market Report Coverage - Single Cell Sequencing
|
|||
|
Base Year
|
2018 |
Market Size
|
$1,234.0 million |
|
Forecast Period
|
2019-2029 |
Value Projection and Estimation by 2029
|
$5,985.6 million |
|
CAGR During Forecast Period
|
15.24% |
Number of Tables
|
10 |
|
Number of Pages
|
189 |
Number of Figures
|
156 |
|
Research Hours
|
280
|
|
|
|
Market Segmentation
|
• Workflow - single cell isolation, single cell amplification, single cell sequencing, and affiliated technological advancements • Product - instruments and consumables • End User - single cell sequencing end user types and single cell sequencing end user preferences |
||
|
Regional Segmentation
|
• North America - U.S. and Canada • Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe • Latin America – Brazil, Mexico, Rest-of-Latin America, and Rest-of-the-World |
||
|
Growth Drivers
|
• Need for Non-Invasive Diagnosis • Advancements in Single Cell Sequencing Techniques |
||
|
Market Challenges
|
• Lack of Tools for Computational Analysis • Lack of Infrastructure and Expertise |
||
|
Market Opportunities
|
• Expansion into Emerging Markets • Expansion into New Research Application • Expansion of the Product Portfolio |
||
|
Key Companies Profiled
|
10x Genomics Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., Celsee Inc., Fluidigm Corporation, Fluxion Biosciences, Illumina, Inc., Mission Bio, NanoString Technologies, Inc., PerkinElmer, Inc., QIAGEN N.V., Takara Bio, Inc., Thermo Fisher Scientific Inc. |
||
Key Questions Answered in this Report
- How much revenue was generated by the global single cell sequencing market in 2018, and how much revenue is expected to be generated by the market by 2029?
- What are the major market drivers, challenges, and opportunities in the global single cell sequencing market?
- How is the global single cell sequencing market expected to grow during the forecast period, on the basis of segments such as
- workflow, including single cell isolation, single cell amplification, single cell sequencing, and affiliated technological advancement
- product, including instruments and consumables
- applications, including oncology, immunology, neurology, microbiology, pre-natal diagnosis (NIPT), and others
- end user, including end-user type (research and academic laboratories, biopharmaceutical and biotech companies, and others)
- region, including North America, Europe, Asia-Pacific, Latin America, Rest-of-the-World
- What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
- What are the key regulatory implications in developed and developing regions for single cell sequencing technology?
- Who are the leading players with significant offerings to the global single cell sequencing market? What is the current market dominance for each of these leading players?
Market Overview
Market Overview
The global single cell sequencing market is undergoing a significant flux with advancements that have already taken place and those that are currently invading the market space. Additionally, the advancements in healthcare applications, such as companion diagnostics, biomarkers, and next-generation sequencing, the demand for precise drugs and tests has increased considerably.
Single cell sequencing encompasses the application of genomic and transcriptomic techniques to the analysis of isolated, individually partitioned single cells. The availability of enhanced sequencing platforms, such as platforms with long-read technologies, enabled the researchers to generate cost-efficient and robust sequence data. The availability of enhanced, smart RNA sequencing and smart sequencing platforms
including long-read technologies, enabled the researchers to generate cost-efficient and robust sequence data.
Advanced sample preparation, reduced cost of sequencing, and increased instrument output are factors that have acted as a proponent of the use of NGS in single cell analysis, especially in the field of single cell genomics and transcriptomics. NGS technology has been used to developed large sets of single cell RNA sequence, tcr single
cell sequencing and single cell DNA sequence libraries of individual cells to enable deep insights on cellular dynamics.
Single cell whole genome sequencing (WGS) allows the characterization and identification of the cells and provides clear insights on the cells from normal to diseased. Several technological advancements in the field of single cell genomics are propagating the growth of this market.
The major factors hindering the market growth are the uncertain reimbursement and regulatory policies, high capital requirement, unavailability of bioinformatics solutions, and high cost of targeted therapeutic drugs and single cell genome sequencing procedures, among others. In addition, the growing geriatric population with an increased prevalence of chronic conditions is the major factor contributing to the increased demand for a single cell sequencing approach.
The global single cell sequencing market accounted for $1,234.0 million in 2018 and is expected to be $5,985.6 million by 2029. The market is anticipated to grow at a CAGR of 15.24% during the forecast period 2019 to 2029. The market growth is attributed to the adoption of early-stage treatments, increased prevalence of chronic diseases, advancements in single cell technology, and an increase in the interests of pharma giants as well as new entrants to venture into the market, among others. Advancements across various fields such as 10x genomics sequencing, 10x genomics single cell rna seq, gene sequencing, companion diagnostics, single cell sequencing, bioinformatics, and big data analytics, are expected to drive market growth during the forecast period.
Competitive Landscape
Current practices of trial and error medicine are getting challenged by rising consumer demand for precise drugs and tests. New digital healthcare start-ups, as well as conventional healthcare players, are challenging market leaders with new technology solutions in the current diagnosis space. One such solution, using new precision care technology, is single cell sequencing. The acceptance of this technology is further enhanced with an increasing availability of genetic testing services.
Continuous innovations (patents), product expansions (launches and enhancements), and signing of partnerships / collaborations are some of the business strategies executed by incumbents as well as new entrants in the single cell sequencing market. Several companies, including 10x Genomics, Inc., Inc., Celsee Diagnostics, Inc. Becton, Dickinson and Company and Mission Bio, among others, were involved in product launches and enhancements. 10x Genomics Inc. was involved in launching the highest number of products with 10 new additions to enhance its product portfolio significantly.
Global Single Cell Sequencing Market
Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive Landscape – Analysis and Forecast, 2018-2029
Similar Product
You may also like
Published Year: 2020
Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Coun
The global precision medicine market is set to witness a CAGR of 11.13% during the period...
Published Year: 2020
Global Companion Diagnostics Market: Focus on Technology, Application Area, Country Data (12 Countri
The global companion diagnostics market to grow at a significant CAGR of 12.45% during the...
Published Year: 2019
Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,
In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...